Sarah Ehlers & Brendan Valentine Parkinson’s Disease.

Slides:



Advertisements
Similar presentations
MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Advertisements

Evaluation of Movement Disorders
The PARticulars of Parkinson’s Disease
Kelsie Chasan Gianni Grasso.  7-10 million diagnosed  60,000 diagnosed each year  Majority over 50 years old  Men more likely.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Parkinson’s Test Device Development Erin Sikkel and Tiffany Feltman.
Module 7.3 Movement Disorders. Parkinson’s Disease A neurological disorder characterized by muscle tremors, rigidity, slow movements and difficulty initiating.
What is Aging? Alzheimer’s Disease Parkinson’s Disease.
Parkinson’s Disease and Treatment Shalla Hanson Medicinal Chemistry April 2009.
Deep Brain Stimulation For parkinson’s disease
 Fibromyalgia By: Nicholas Bono. What is fibromyalgia?  Fibromyalgia is a common syndrome in which an individual may experience long-term, body wide.
Erica Partridge Parkinson’s Disease. Definition Aetiology PD vs Parkinsonism Symptoms and signs Differentials Investigations Management Prognosis.
Gene Therapy in Huntington’s Disease Project was done by Rejan Chin & Sharisa Ford.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Parkinson’s Disease By Devin Cornford
The Mature Adult The Mature Adult Chapter 12: The Mature Adult J Pistack MS/Ed J Pistack MS/Ed.
Osteoporosis Daniel D Erica.
Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative.
Huntington Disease Genetic Disorder Project Alaukika Desai AP Biology Period 3.
Prevention and management of diseases among elderly Ahmad Osailan.
Parkinson’s Disease. Definition Parkinson's disease (PD) is an idiopathic, slowly progressive, neurodegenerative disorder whereby two or more of the following.
Surgery for Parkinson’s Disease: Focus on Deep Brain Stimulation Ramón L Rodríguez, MD Director of Clinical Services University of Florida Movement Disorders.
BY: MACKENZIE SOARES ALYSSA MEDIEROS STEPHANIE GARDNER Parkinson's Disease.
PARKINSON’S DISEASE By Courtney and Niral. WHAT IS IT?  Parkinson's disease (PD) is chronic and progressive movement disorder, meaning that symptoms.
Innovations in Parkinson’s Diagnosis & Treatment: A Personal Story Dr. Kenneth E. Keirstead Excellence in Aging Care Symposium September 25-27, 2013.
Adult Medical-Surgical Nursing Neurology Module: Parkinson’s Disease.
Treatment of Parkinson’s Disease Christopher Buchanan CHEM 5398/Buynak April 3, 2007.
Mostly Parkinson’s disease but also few other movement disorders due to diseases of the basal ganglia.
Parkinson’s Disease by Jessica Teen Health 8 Definition *Parkinson’s Disease is a disorder of the brain characterized by shaking and having difficulty.
 Parkinson Disease (PD) is a disorder of the brain that causes a variety of movement problems.
PARKINSON’S DISEASE By: AARUSHI JAIN AMRUTA KAMBLE ANNETT MARY JACOB AVANTI DEO M.Sc. PRIST (09-11)
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults.
How are medicines developed?. What is it? What’s inside?
HOLLY CAMPBELL-BARR, LAUREN GAY AND LUCY GODDEN. The effect of drugs on the brain…
Parkinson's disease Carlo Varas. Definition progressive disorder of the nervous system that affects movement. tremor may be the most well-known sign of.
By: Alejandro Navarro and Andrea Ors. Content Introduction What is Parkinson's disease? What causes the disease? History Main symptoms Treatment Statistics.
Neurological Disorders
By Katelyn Chaimson and Sean Guyot
Alyssa Carto Audience: Patients with or caregivers to those with Parkinson’s Disease.
Parkinson's disease By Colby Allen. symptoms Mild to major tremors. Rigidity or joint stiffness Bradykinesia or slowness of movement Postural instability.
The Substantia Nigra THE BRAIN Symptoms differ from every person suffering from the disease. There are two types of symptoms, primary, secondary.
Parkinson’s Disease Sheila Mulhern. Parkinson’s Disease Stats (PDF)  One million Americans live with Parkinson's disease, - more than the combined number.
 Parkinson Disease (PD) is a progressive disorder of the central nervous system that often impairs the sufferer's motor skills, speech, and other functions.
Parkinson’s Test Device Development Tiffany Feltman Erin Sikkel.
Definition  Alzheimer's disease, it is a brain disorder, is most commonly to forget things&affects a person's ability to accomplish daily activities.
By Seamus Hogan.  Parkinsons disease is degenerative disorder of the central nervous system. it causes the dopamine to contain cells in the substantial.
Huntington’s Disease BY: SAM DAVIS, SABRINA TRAN, MYA LUNA, MYLES BLACKWELL AND EAMONN DUENSING.
Neurotransmitters in the brain By Joon Kim. Neurotransmitters  A neurotransmitter is a specialized messenger chemical that transfers or sends information.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Emma Hahs, Brooke Armistead, Sarah Brown, Sok Kean Khoo Department of Cell and Molecular Biology, College of Liberal Arts and Sciences, Grand Valley State.
Parkinson’s Disease By: Taylor Hawkins, Ana McGhee, and Morgan Zander.
How is Parkinson’s disease Diagnosed? And What Are the Treatment options?
Parkinson's disease ♦ Is a neurodegenerative disorder ♦ Develops around age 50 * incidence rises with age * affects 1-2% of population > age 65 ♦ Higher.
PARKINSON’S DISEASE CHAMINDA UNANTENNE RN,MS,MSN.
Team (Phoenix) Presents Parkinson’s Disease Prepared in partial satisfaction of the requirements for GPC 126, Physiological Psychology Spring Semester,
“HEALTH IS THE BEST” In the name of God. WHAT IS IT? Parkinson's disease (PD) is a chronic and progressive movement disorder, meaning that symptoms.
Disabilities – Part One RECR 120. Parkinson’s Disease Non-motor symptoms such as loss of smell, constipation, and sleep disorders may appear years before.
PARKINSON’S DISEASE LUKE CARROLL & LAUREN DESROCHES.
Module 7.3 Movement Disorders
Parkinson’s Disease Celsey and Chylee.
Parkinson's disease KRZYSZTOF NICPOŃ.
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Parkinson’s disease.
Long Term Effects of Concussions
Neil Madadi, Jasmyne Post, Marie McClary, Kalen Carper
Lucas McDuff and Meghan Mumpower
Drugs for Degenerative Diseases of the Nervous System
Lucas McDuff and Meghan Mumpower
HOW DOES EXPERIENCE AFFECT BEHAVIOUR AND MENTAL PROCESSES?
Presentation transcript:

Sarah Ehlers & Brendan Valentine Parkinson’s Disease

Description A progressive disorder of the nervous system Symptoms: Tremors Slowed Movement (bradykinesia) Rigid Muscles Impaired Posture and Balance Loss of Automatic Movements Speech Changes Writing Changes (1)

Stages Stage 1 - one side of the body is affected Stage 2- both sides of the body affected; balance intact Stage 3- balance impaired, but not independent functioning Stage 4- walking or standing difficult with out assistance Stage 5- bedridden or wheel chair bound with out assistance

Examples

Risk Factors Age. Young adults rarely experience Parkinson's disease. It ordinarily begins in middle or late life, and the risk continues to increase with age. Heredity. Having a close relative with Parkinson's disease increases the chances that you'll also develop the disease. However, your risks are still small unless you have many relatives in your family with Parkinson's disease. Sex. Men are more likely to develop Parkinson's disease than are women. Exposure to toxins. Ongoing exposure to herbicides and pesticides may put you at a slightly increased risk of Parkinson's disease.

Etiology Specific etiology is unknown (6) Related to loss of brain chemicals Cells in the substantia nigra part of the brain degenerate these cells make dopamine Decreased dopamine lead to increased muscle tension and tremor (3,4)

Diagnosis Medical History and Clinical Examination Motor Symptoms Bradykinesia (slow voluntary movements Tremors (involuntary movements) Rigidity Posture Olfactory Dysfunction Sleep behavior Depression Cognitive Decline Diagnosis can only be certain post mortem (2)

Statistics Each year, approximately 60,000 Americans are diagnosed with Parkinson's disease. Prevalence Rate: approx 1 in 272 or 0.37% or 1 million people in USA It appears to affect whites more than African Americans or Asians. Not even 10% of cases are diagnosed in adults under age 40. Most of the fresh diagnoses are in those above age 60. Men are one and a half times more likely to have Parkinson's than women. Medication costs for an individual person with PD average $2,500 a year, and therapeutic surgery can cost up to $100,000 dollars per patient. (5)

PD and Nutrition IncreaseDecrease Magnesium- deficiency symptoms similar to PD symptoms and sleep support Vitamin D- enhances brain- derived neurotropic factor (basically growth hormone for neurons) & anti- inflammatory Omega-3’s-Mood-boosting & anti-inflammatory Homocystein- toxic if elevated & found at high levels in people with PD folic acid, vitamins B12 and B6, zinc and tri- methyl-glycine (some co- factors dopamine production) (7)

Affects on Nutrition Unintentional Weight LossLong Term Increased EE: Tremors, Dyskinesia, Rigidity Reduced Intake: Olfactory changes Dysphasia Reduced peripheral ability Medicinal Complications (7) Increased Hospital Stays Decreased bone density Increased chances of fractures Depression Loss of muscle mass Introduction of new chronic disease Death (7)

Treatment Levodopa with dopadecarboxylase inhibitor The most effective treatment available for Parkinson’s Dopamine and Serotonin Inhibitor Eventually a wearing off effect will occur Results in dyskinesia (involuntary movements, tics) Debate over when to start treatment in patients under 50 (8)

Surgical Treatment Option Deep Brain Stimulation (DBS) Surgically places electrode in the brain Does not damage healthy brain tissue Blocks electrical signals from targeted areas in the brain. Helps treat tremor, slowness, rigidness (10)

Role of the Dietitian Team Approach Registered dietitian must work with the primary care physician, a neurologist and, the SLP when dysphasia is present Develop a menu meeting the needs for: Folic acid Vitamins B12 and B6 Zinc Magnesium Vitamin D Omega 3’s Work with the SLP on how the diet must be administered (7)

Case Study Patient 72 year old female Stage 4 Nursing home resident Severe tremors Holding silverware is difficult Dysphasia present Experiencing unintentional weight loss

Treatment Options Levodopa medication Adaptive eating utensils Pureed diet high in magnesium, vitamin D, and omega 3’s Weight training, tai chi, yoga exercises (if cleared by doctor) with assistance Swallowing techniques, exercises, rehab with SLP Monitor and watch for signs and symptoms of weight loss, malnutrition, and act with the SLP to change diet accordingly

References 1. Mayo Clinic. Parkinson's Disease. disease/DS00295 (accessed April 14, 2013). 2. Lingor, P., Liman, J., Kallenberg, K., Sahlmann, C., Bahr, M.. Diagnosis and Differential Diagnosis of. Intech.2011;1(1): Gaenslen A, Gasser T, Berg D. Nutrition and the risk for Parkinson's disease: review of the literature. Journal Of Neural Transmission (Vienna, Austria: 1996) [serial on the Internet]. (2008, May), [cited April 15, 2013]; 115(5): Available from: MEDLINE with Full Text disease.aspx 8. Holden, K.E.. Unintentional Weight Loss and Its Management. Nutrition in Clinical Care.2001;4(3): Worth, P.F.. How to treat Parkinson's disease in Clinical Medicine.2013;13(1): Brain-Stimulation